Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Aethlon Medical (AEMD) FCF Margin (2016 - 2023)

Aethlon Medical (AEMD) has disclosed FCF Margin for 13 consecutive years, with 515.11% as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, FCF Margin rose 2473249.0% year-over-year to 515.11%, compared with a TTM value of 1875.22% through Dec 2023, up 8810426.0%, and an annual FY2025 reading of 164.1%, changed N/A over the prior year.
  • FCF Margin was 515.11% for Q1 2023 at Aethlon Medical, up from 25247.61% in the prior quarter.
  • Across five years, FCF Margin topped out at 310.67% in Q4 2019 and bottomed at 25247.61% in Q1 2022.
  • Average FCF Margin over 5 years is 5359.1%, with a median of 1599.05% recorded in 2021.
  • The sharpest move saw FCF Margin crashed -1869287bps in 2022, then surged 2473249bps in 2023.
  • Year by year, FCF Margin stood at 310.67% in 2019, then dropped by -15bps to 356.7% in 2020, then plummeted by -4447bps to 16218.1% in 2021, then plummeted by -56bps to 25247.61% in 2022, then soared by 98bps to 515.11% in 2023.
  • Business Quant data shows FCF Margin for AEMD at 515.11% in Q1 2023, 25247.61% in Q1 2022, and 16218.1% in Q4 2021.